|
Linrong Lu, Professor, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
T-Cell | Biology | Cell Signaling | Immunology | Immune Regulation | Autoimmune | Tumor | Cancer | Research | Therapy |
|
Pengxu Qian, Researcher of the 'Hundred Talents Program', Tenured Associate Professor, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Stem Cells | Hematopoiesis | Blood | Regeneration | Transplantation | Epigenetic Regulation | Gene Expression | Cancer | Therapy | Nanotechnology |
|
H. Wang, Principal Investigator, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Cancer | Nanomedicine | Drug Delivery | Biochemistry | Molecular Engineering | Photodynamic | Nanoparticles | Prodrug | Biomaterials | Immunotherapy |
|
Ying Yuan, Chief Physician, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Personalized Medicine | Cancer | Oncology | Treatment | Genetics | Colorectal Cancer | Molecular Mechanisms | Research | Therapy | Hereditary |
|
Wan Zhuo Xie, Chief Physician, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Hematology | Internal Medicine | Malignant Diseases | Clinical Research | Basic Research | Lymphoma | Blood Disorders | Cancer | Immunology | Therapy |
|
Tianan Jiang, Chief Physician, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Ultrasound | Diagnosis | Interventional | Therapy | Liver | Cancer | Ablation | Imaging | Fusion | Navigation |
|
Runzhi Zhu, Researcher | Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Tumor | Development | Mechanism | Drug | Intervention | Cancer | Therapy | Research | Oncology | Treatment | Acute | Liver | Failure | Hepatology | Disease | Medicine | Health |
|
Yishan Ye, Associate Researcher, Master's Supervisor
Zhejiang University, Medical
Area of Focus
Hematology | Blood Disorders | Stem Cells | Transplantation | Immunology | Immune Response | Microbiota | Cancer | Therapy | Clinical Trials |
|
Longguang Tang, Researcher, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Drug Delivery | Lysosome | Protein Degradation | Molecular Imaging | Probes | Cancer | Stroke | Nanomedicine | Antibody-Drug Conjugates | Small Molecule Drugs |
|
Hangping Yao, Researcher | Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Infectious Diseases: Infection | Immunity | Pathogens | Rapid Identification | H7N9 | Avian Influenza | Vaccine | Public Health | Outbreak | Control | Infection And Cancer: Infection | Cancer | Immune Response | Tumor Microenvironment | Oncogenesis | Chronic Infection | Viral Oncogenesis | Bacterial Oncogenesis | Inflammation | Therapy | Tumor Biology And Targeted Therapy: Tumor | Biology | Targeted Therapy | Ron Receptor | Monoclonal Antibodies | Immunohistochemistry | Prognosis | Molecular Mechanisms | Drug Targets | Cancer Treatment | Preclinical Research Of Antibodies And Antibody Drugs: Antibodies | Preclinical Research | Drug Development | Adc | Efficacy | Safety | Cancer Therapy | Humanized Antibodies | Clinical Application |
